Registry for patients taking pitavastatin
The Polish Mother's Memorial Hospital Research Institute Pitavastatin Registry
This study is collecting information from patients taking pitavastatin to see how well it works and how safe it is in everyday use for heart and cholesterol management.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 500 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Polish Mother Memorial Hospital Research Institute Academic / other |
| Locations | 1 site (Lodz) |
| Trial ID | NCT06858982 on ClinicalTrials.gov |
What this trial studies
The PMMHRI-Pitavastatin Registry is a non-interventional, single-center registry at the Polish Mother's Memorial Hospital Research Institute that began in January 2024. It enrolls patients from cardiology and endocrinology departments who are prescribed pitavastatin to collect real-world data on its effectiveness and safety. The registry aims to evaluate treatment patterns and outcomes by analyzing demographic data, comorbidities, medications, lifestyle factors, and laboratory parameters. This comprehensive approach allows for a better understanding of pitavastatin's impact on lipid and cardiovascular risk management in routine clinical practice.
Who should consider this trial
Good fit: Ideal candidates for this registry are patients prescribed pitavastatin according to the 2021 Polish Lipid Guidelines.
Not a fit: Patients not taking pitavastatin or those who do not meet the inclusion criteria will not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could provide valuable insights into the effectiveness and safety of pitavastatin, potentially improving treatment strategies for hypercholesterolemia.
How similar studies have performed: While this registry approach is common, the specific focus on pitavastatin in a Polish context may provide novel insights into its use and effectiveness.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * patient takling pitavastatin based on the 2021 Polish Lipid Guidelines Exclusion Criteria: \-
Where this trial is running
Lodz
- Polish Mother's Memorial Hospital Research Institute — Lodz, Poland (Recruiting)
Study contacts
- Study coordinator: Maciej Banach, MD,PhD, FNLA, FAHA,FESC, FASA
- Email: maciej.banach@icloud.com
- Phone: +48 42 2711599
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.